Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07325474 · ClinicalTrials.gov registry record · NA
Plan and Protect: Safety Planning for Teens in Rural Emergency Departments
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 550
- Enrollment target
NCT07325474: Clinical Trial NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT07325474 is a NA study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 550 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07325474, a NA study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
Study Summary
The goal of this observational study is to determine whether implementing a culturally sensitive, tablet-based safety planning program called Plan \& Protect (P\&P) within rural emergency departments can improve home safety and reduce suicide risk in adolescents presenting with suicidality. The main questions it aims to answer are: * Will implementing P\&P increase caregiver-reported home safety (reduce access to firearms and unsafe medication storage) for adolescents 12-17 years old presenting to rural EDs with suicidal ideation, self-harm, or mental health crisis? * Will implementing P\&P decrease adolescent-reported perceived suicide risk and related outcomes (e.g., suicide events, and attendance at follow-up mental healthcare)? Researchers will compare outcomes for adolescents and caregivers receiving P\&P (implemented as the new standard of care at sites during the intervention periods) to those receiving usual care (prior to P\&P implementation at those hospitals) to see if P\&P increases home safety and decreases suicide risk and related healthcare utilization. Participants will, if clinically appropriate: * Complete the tablet-based P\&P modules during their ED visit * Complete self-report measures at baseline, \~30 days, and \~3 months post-discharge * A subset will also participate in semi-structured interviews
Primary Outcome
Reduced access to firearms and medications at home. This will be collected with five questions about presence of medications and firearms at home, if they are stored unlocked, and if firearms are loaded. We will measure improvement in safety across the time frame.
Interventions
- BEHAVIORAL Plan & Protect safety planning intervention
- BEHAVIORAL Care as usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-09-30 |
| Phase | NA |
What is known before NCT07325474 opens enrollment
NCT07325474 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 2 interventions - of which Plan & Protect safety planning intervention is the first listed.
NCT07325474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07325474 about?
NCT07325474 is a clinical study titled "Plan and Protect: Safety Planning for Teens in Rural Emergency Departments". The goal of this observational study is to determine whether implementing a culturally sensitive, tablet-based safety planning program called Plan \& Protect (P\&P) within rural emergency departments can improve home safety and reduce suicide risk in adolescents presenting with suicidality. The mai...
What is the current status of trial NCT07325474?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2026-06-01. Estimated completion is 2028-09-30.
What interventions are being tested in trial NCT07325474?
The interventions under investigation include: Plan & Protect safety planning intervention (BEHAVIORAL), Care as usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT07325474?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07325474's enrollment target sits among peer trials
550 184th of 2000 higher than 1,815 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI